Public data workspaceRead-only tender record
Public tender

Doxycycline Injectable Supply for Canadian Armed Forces Medical Countermeasures

The Strategic Medical Countermeasures Program (SMCP) on behalf of the Canadian Forces Health Services Group (CF H Svcs Gp), Department of National Defence (DND), has a requirement for Doxycycline injectable for the treatment of Canadian Armed Forces (CAF) members who may have been exposed to bacterial biological warfar…

Source ID: CA-NOTICE-cb-909-95115835-002

Scope overview

The Strategic Medical Countermeasures Program (SMCP) on behalf of the Canadian Forces Health Services Group (CF H Svcs Gp), Department of National Defence (DND), has a requirement for Doxycycline injectable for the treatment of Canadian Armed Forces (CAF) members who may have been exposed to bacterial biological warfare agents.

The initial requirement is for the supply of 30,240 units of Doxycycline Hyclate 100mg for injection delivered to Petawawa, Ontario, Canada on or before 31 March 2026. Additionally, the Contracting Authority may exercise the option to acquire up to 60,480 additional units on an “as and when requested basis” over the lifetime of the contract.

The product supplied must be in the dosage form of lyophilized powder for reconstitution administered by injection and following the criteria listed in Annex A of the Request for Proposal. The period of the contract will be from contract award until 31 March 2030.

All enquiries are to be submitted to the Contracting Authority by email no later than 10 calendar days before the bid closing date: Contracting Authority: Safiya Motala Email Address: safiya.motala@forces.gc.ca Responses and amendments will be available from the same government electronic tendering service, CanadaBuys.

Bids must be submitted only to the Public Services and Procurement Canada (PSPC) Bid Receiving Unit via Canada Post Corporation's (CPC) Connect service by the date, time and place indicated in the bid solicitation.

Notice type: Request for Proposal Procurement method: Competitive - Open bidding Selection criteria: Lowest Price Trade agreements: *Canada-UK Trade Continuity Agreement (Canada-UK TCA) *Canada-European Union Comprehensive Economic and Trade Agreement (CETA) *Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP) *World Trade Organization Agreement on Government Procurement (WTO GPA) *Canada-Peru Free Trade Agreement (CPFTA) *Canada-Honduras Free Trade Agreement *Canada-Colombia Free Trade Agreement *Canada-Ukraine Free Trade Agreement (CUFTA) *Canada-Chile Free Trade Agreement (CCFTA) *Canada-Korea Free Trade Agreement (CKFTA) *Canada-Panama Free Trade Agreement *Canadian Free Trade Agreement (CFTA) Regions of delivery: *Canada Contact: Safiya Motala (safiya.motala@forces.gc.ca) None

Statusopen
CategoryHealthcare & Medical
CountryCanada
Publish dateOct 22, 2025
Submission deadlineDec 11, 2025
Estimated value
Notice typetender_notice
Sourceca-canadabuys-notices
BuyerDepartment of National Defence (DND)
Buyer websitehttps://canadabuys.canada.ca/
CityOttawa

Buyer & contacts

Public read-only access
Contact fields are visible publicly. Use the workspace for exports, buyer tracking, and alerts.
Open workspace
Emailsafiya.motala@forces.gc.ca
OrganizationDepartment of National Defence (DND)

Documents

Public document access
Source documents are listed publicly. Use the workspace for OCR, search, and one-click packs.
Open workspace

Tags & Signals

doxycycline injectablemedical countermeasuresbiological warfare treatmentCanadian Armed Forcespharmaceutical supplydefense procurementlyophilized powderemergency medication
Unlock actions

Keep reading for free. Pay only when you need workspace actions.

This record stays public. Upgrade only when you want alerts, exports, OCR packs, and autopilot workflows inside the private workspace.

Disclaimer: IndexBox Tenders does not issue, announce, or publish this tender. This information is aggregated from publicly available sources and is provided for informational purposes only. IndexBox Tenders is not affiliated with, endorsed by, or acting on behalf of the tender issuer. Users should verify all information directly with the official tender source before making any decisions or taking any action.